RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo

Pancreatic neuroendocrine tumors (pNETs) are difficult-to-treat neoplasms whose incidence is rising. Greater understanding of pNET pathogenesis is needed to identify new biomarkers and targets for improved therapy. RABL6A, a novel oncogenic GTPase, is highly expressed in patient pNETs and required f...

全面介绍

书目详细资料

Principais autores:	Chandra K. Maharjan, Shaikamjad Umesalma, Courtney A. Kaemmer, Viviane P. Muniz, Casey Bauchle, Sarah L. Mott, K. D. Zamba, Patrick Breheny, Mariah R. Leidinger, Benjamin W. Darbro, Samuel B. Stephens, David K. Meyerholz, Dawn E. Quelle
格式:	Artigo
语言:	Inglês
出版:	MDPI AG 2021-06-01
丛编:	Biomedicines
主题:	pancreatic neuroendocrine tumors RIP-Tag2 mouse model RABL6A angiogenesis <i>c-Myc</i>
在线阅读:	https://www.mdpi.com/2227-9059/9/6/633
标签:	添加标签 没有标签, 成为第一个标记此记录!